Skip to content

Prospective Feasibility Trial of AccuCath 2.25 Blood Control (BC) Placed in Difficult Access Patients in the Emergency Department

A Prospective Feasibility Trial of AccuCath 2.25 BC Intravascular Catheter System With Retractable Coiled Tip Guidewire Placed in Difficult Access Patients in the Emergency Department

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02449798
Enrollment
120
Registered
2015-05-20
Start date
2015-03-31
Completion date
2015-07-31
Last updated
2017-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Access Complication

Keywords

Difficult IV access, AccuCath, IV outcomes, patient satisfaction

Brief summary

Study objective is to evaluate user preference, time for procedure, insertion success rates, complications, completion of therapy and dwell time of the AccuCath 2.25 BC device placed in difficult IV access patients in the emergency department.

Detailed description

A one arm, prospective feasibility study using the AccuCath 2.25 BC Intravascular Catheter System placed in the upper arm with ultrasound guidance, and the lower arm with and without ultrasound guidance based on clinical assessment. Subjects will be subjected to a maximum of 4 attempts. If unsuccessful by the 4th attempt, alternatives will be considered as per current standard of care. Currently multiple IV attempts are made in difficult IV access patients without success. Patients are often escalated to more invasive lines due to the need for longer catheters without clinical indication. The study will evaluate the feasibility of AccuCath 2.25 BC as a low risk, lower cost alternative for this patient population in lieu of using a midline, peripherally inserted central line or central venous catheter when not clinically required for purposes of therapy.

Interventions

DEVICEAccuCath 2.25 BC Intravascular Catheter

Long peripheral IV catheter designed for difficult IV access patients requiring deeper vessel access, often used with ultrasound guidance.

Sponsors

C. R. Bard
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male or female, age \> 18 years old; 2. Capable and willing to give informed consent; 3. English speaking; 4. Acceptable candidate for an elective, non-emergent peripheral IV as determined by ordering physician; 5. Admitted to inpatient area for minimum of 24 hours, preferably for average hospital length of stay; 6. Difficult venous access patient as defined by either 2 failed initial attempts without ultrasound guidance or a history of difficult access plus the inability to directly visualize or palpate a target vein.

Exclusion criteria

1. Male or female, \< 18 years old; 2. Requirement for emergent IV placement (patient's condition would be compromised if there is a delay in IV placement); 3. Previous venous grafts or surgery at the target vessel access site; 4. Subjects with lymphedema or status-post mastectomy on affected side; 5. Currently involved in other investigational clinical trials (unless permission is granted by other study PI).

Design outcomes

Primary

MeasureTime frame
Number of Catheter Attempts Required to Complete Successful PIV PlacementAt IV insertion attempt, generally from 3-15 minutes
First Attempt Success RateAt initial IV insertion attempt, generally from 3-15 minutes

Secondary

MeasureTime frameDescription
ComplicationsDuring IV dwell from initial insertion success through IV removal, usually ranges from 7-14 days but could be up to 29 daysCount of IV complications that require IV removal before completion of therapy. Includes infiltration, extravasation, phlebitis, occlusion, dislodgement, infection, leaking at site, pain at site
Dwell TimeDuration of IV dwell from initial insertion success through IV removal, usually ranges from 0-336 hours (0-14 days) but could be up to 696 hours (29 days)IV dwell time in hours until IV is no longer needed or complicates.
Patient SatisfactionAt end of IV insertion, first 3-15 minutes of procedureA 5-point Likert scale (1-5) was used for measurement of satisfaction with overall IV insertion experience. A score of 1 indicated the lowest satisfaction, while a score of 5 indicated the highest satisfaction. A score of 3-5 was considered positive.
Completion of TherapyDuring IV dwell from initial insertion success through IV removal, usually ranges from 7-14 days but could be up to 29 daysCount of whether the catheter lasted for the duration of intended therapy without complication requiring early removal.
Time to Catheter PlacementAt initial IV insertion attempt through successful cannulation, generally from 3-15 minutesTime will be measured from initial vessel insertion through successful cannulation

Other

MeasureTime frameDescription
Number of Attempts Prior to AccuCath 2.25 UseNumber of IV attempts made before patient identified as difficult access and enrolled in study, could range from 3-30 minutes during initial procedure attemptsCount of catheter attempts during initial insertion before patient identified as difficult IV access

Countries

United States

Participant flow

Participants by arm

ArmCount
AccuCath 2.25 BC Intravascular Catheter
Use of AccuCath 2.25 BC peripheral IV device for difficult IV access in emergency room patients who have had 2 previous attempts, identified as difficult IV access from patient history or non-palpable, non-visible veins. AccuCath 2.25 BC Intravascular Catheter: Long peripheral IV catheter designed for difficult IV access patients requiring deeper vessel access, often used with ultrasound guidance.
120
Total120

Baseline characteristics

CharacteristicAccuCath 2.25 BC Intravascular Catheter
Age, Continuous56.5 Year
STANDARD_DEVIATION 19.06
Race/Ethnicity, Customized
Asian
6 participants
Race/Ethnicity, Customized
Black
47 participants
Race/Ethnicity, Customized
Caucasian
55 participants
Race/Ethnicity, Customized
Latino
11 participants
Race/Ethnicity, Customized
Other
1 participants
Sex: Female, Male
Female
79 Participants
Sex: Female, Male
Male
41 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
6 / 120
serious
Total, serious adverse events
0 / 120

Outcome results

Primary

First Attempt Success Rate

Time frame: At initial IV insertion attempt, generally from 3-15 minutes

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
AccuCath 2.25 BC Intravascular CatheterFirst Attempt Success Rate92 Participants
Primary

Number of Catheter Attempts Required to Complete Successful PIV Placement

Time frame: At IV insertion attempt, generally from 3-15 minutes

ArmMeasureValue (MEDIAN)
AccuCath 2.25 BC Intravascular CatheterNumber of Catheter Attempts Required to Complete Successful PIV Placement1 Number of Catheters
Secondary

Completion of Therapy

Count of whether the catheter lasted for the duration of intended therapy without complication requiring early removal.

Time frame: During IV dwell from initial insertion success through IV removal, usually ranges from 7-14 days but could be up to 29 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
AccuCath 2.25 BC Intravascular CatheterCompletion of Therapy102 Participants
Secondary

Complications

Count of IV complications that require IV removal before completion of therapy. Includes infiltration, extravasation, phlebitis, occlusion, dislodgement, infection, leaking at site, pain at site

Time frame: During IV dwell from initial insertion success through IV removal, usually ranges from 7-14 days but could be up to 29 days

Population: The total number of complications resulting from all 120 IV placement procedures is reported.

ArmMeasureValue (NUMBER)
AccuCath 2.25 BC Intravascular CatheterComplications18 Complications
Secondary

Dwell Time

IV dwell time in hours until IV is no longer needed or complicates.

Time frame: Duration of IV dwell from initial insertion success through IV removal, usually ranges from 0-336 hours (0-14 days) but could be up to 696 hours (29 days)

Population: Admitted patients

ArmMeasureValue (MEDIAN)
AccuCath 2.25 BC Intravascular CatheterDwell Time90.98 hours
Secondary

Patient Satisfaction

A 5-point Likert scale (1-5) was used for measurement of satisfaction with overall IV insertion experience. A score of 1 indicated the lowest satisfaction, while a score of 5 indicated the highest satisfaction. A score of 3-5 was considered positive.

Time frame: At end of IV insertion, first 3-15 minutes of procedure

ArmMeasureValue (MEDIAN)
AccuCath 2.25 BC Intravascular CatheterPatient Satisfaction5 units on a scale
Secondary

Patient Satisfaction

A 5-point Likert scale (1-5) was used for measurement of satisfaction with overall IV performance at IV removal. A score of 1 indicated the lowest satisfaction, while a score of 5 indicated the highest satisfaction. A score of 3-5 was considered positive.

Time frame: at IV removal, which can be up to a maximum of 29 days

ArmMeasureValue (MEDIAN)
AccuCath 2.25 BC Intravascular CatheterPatient Satisfaction5 units on a scale
Secondary

Time to Catheter Placement

Time will be measured from initial vessel insertion through successful cannulation

Time frame: At initial IV insertion attempt through successful cannulation, generally from 3-15 minutes

ArmMeasureValue (MEDIAN)
AccuCath 2.25 BC Intravascular CatheterTime to Catheter Placement2 minutes
Other Pre-specified

Number of Attempts Prior to AccuCath 2.25 Use

Count of catheter attempts during initial insertion before patient identified as difficult IV access

Time frame: Number of IV attempts made before patient identified as difficult access and enrolled in study, could range from 3-30 minutes during initial procedure attempts

ArmMeasureValue (MEDIAN)
AccuCath 2.25 BC Intravascular CatheterNumber of Attempts Prior to AccuCath 2.25 Use3 number of attempts

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026